Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/UK EMC/Olanzapine 7.5 mg tablets

Approved

STANDARD

Olanzapine 7.5 mg tablets

Ranbaxy (UK) Limited a Sun Pharmaceutical Company🇬🇧 Electronic Medicines Compendium

Approval Date: N/A
Approval ID: 7fa6b8f3a2645d7d
Company: Ranbaxy (UK) Limited a Sun Pharmaceutical Company
Type: Standard

Approval Details

Approval Id: 7fa6b8f3a2645d7d
Drug Approval Emc Name: Olanzapine 7.5 mg tablets
Drug Name: Olanzapine 7.5 mg tablets
Company Name: Ranbaxy (UK) Limited a Sun Pharmaceutical Company
Company Address: 6-9 The Square, Stockley Park, Uxbridge, UB11 1FW, UK
Company Website: http://www.sunpharma.com
Company Telephone: +44 (0) 208 848 8688
Company Medical Info Direct Line: +44 (0) 208 848 5052
Company Medical Info Email: medinfoeurope@sunpharma.com
Legal Category: Prescription only medicine

Active Ingredients

Approved

Quick Info

Agency

UK EMC

Country

🇬🇧

Approval ID

7fa6b8f3a2645d7d

Type

Standard

Back to UK EMC Approvals

Olanzapine 7.5 mg tablets - UK EMC Drug Approval Details